Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-27

Clinical Trial Update: Effect of Tirzepatide and Bimagrumab on Body Composition, Insulin Sensitivity, and Bone in Adults With Obesity [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of tirzepatide and bimagrumab on body composition, insulin sensitivity, and bone health in adults with obesity; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimagrumab (bimagrumab)
  • Tirzepatide (tirzepatide)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obesity | Phase 2 | Status: RECRUITING